GBT2104-133 - An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
January 11, 2023
End Date
September 30, 2027
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
January 11, 2023
End Date
September 30, 2027